Source: Autobound Signal API · 102 signals tracked for Eli Lilly · updated
Get Eli Lilly's live signals in Claude or ChatGPT, or by API
What changed at Eli Lilly this week? Use Autobound signals for lilly.com.Eli Lilly launched Foundayo in the U.S. in the second quarter of 2026 and submitted it to the FDA for type 2 diabetes. Commercial execution around new product lines may demand increased sales enablement, marketing technologies, and commercial operations support.
Filing excerpt
In the second quarter of 2026, we launched Foundayo (orforglipron) in the U.S. for the treatment of obesity and submitted orforglipron to the FDA for type 2 diabetes.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qproductLaunchGet every 10-Q signal for Eli Lilly and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Eli Lilly this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/7590ba57-7106-4903-ac23-0546202c75eb returns this record as JSON. POST /v1/companies/enrich returns every signal for lilly.com.
{
"signal_id": "7590ba57-7106-4903-ac23-0546202c75eb",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-11-03T07:05:04.566+00:00",
"company": {
"name": "Eli Lilly",
"domain": "lilly.com"
},
"data": {
"detail": "Eli Lilly launched Foundayo in the U.S. in the second quarter of 2026 and submitted it to the FDA for type 2 diabetes. Commercial execution around new product lines may demand increased sales enablement, marketing technologies, and commercial operations support.",
"metrics": {
"timeframe": "current_year"
},
"quarter": "Q3",
"summary": "Eli Lilly launched Foundayo (orforglipron) for obesity treatment in the U.S.",
"excerpts": "In the second quarter of 2026, we launched Foundayo (orforglipron) in the U.S. for the treatment of obesity and submitted orforglipron to the FDA for type 2 diabetes.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/lly-20260930.htm",
"filing_date": "2026-10-29",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "09/30",
"period_end_date": "2026-09-30",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/7590ba57-7106-4903-ac23-0546202c75eb \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"lilly.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.